<DOC>
	<DOCNO>NCT00584870</DOCNO>
	<brief_summary>The primary objective study evaluate analgesic efficacy RN624 compare placebo compare naproxen treatment adult patient chronic low back pain .</brief_summary>
	<brief_title>RN624 In Adult Patients With Chronic Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Male female race , &gt; 18 year age BMI ≤39 kg/m2 Present duration chronic low back pain ≥3 month require regular use analgesic medication ( &gt; 4 day per week past month ) Primary location low back pain 12th thoracic vertebra low gluteal fold , without radiation posterior thigh , classify Category 1 2 accord classification Quebec Task Force Spinal Disorders Must score ≥4 Low Back Pain Intensity ( NRS ) current treatment Screening , complete least 4 daily pain diary 5 day prior Randomization , average Low Back Pain Intensity ( NRS ) score ≥4 Back pain due visceral disorder ( i.e . endometriosis ) Back pain due recent major trauma ( i.e . vertebral fracture , posttraumatic spondylolisthesis ) History lumbosacral radiculopathy , spinal stenosis associate neurological impairment , neurogenic claudication Osteoporotic compression fracture within last 6 month Known history : Rheumatoid arthritis ; Seronegative spondyloarthropathy ( i.e. , ankylose spondylitis , psoriatic arthritis , reactive arthritis , inflammatory bowel diseaserelated arthropathy ) ; Paget 's disease spine , pelvis femur ; Fibromyalgia ; Tumors infection spinal cord Patients receive acetaminophen manage chronic low back pain Any uncontrolled untreated chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>